You can thank me ...
Tech Times on MSN
Fresenius signs largest-ever biosimilar deal with WuXi Biologics; US ban decision due in six weeks
Fresenius WuXi Biologics biosimilar deal is the largest ever signed: 37 drug candidates targeting $414 billion in annual revenues, arriving six weeks before the US Office of Management and Budget ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results